Cullen/Frost Bankers, Inc. Medpace Holdings, Inc. Transaction History
Cullen/Frost Bankers, Inc.
- $6.83 Billion
- Q2 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 116 shares of MEDP stock, worth $38,447. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 100
16.0%
Holding current value
$38,447
Previous $40,000
17.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MEDP
# of Institutions
654Shares Held
25.6MCall Options Held
38.7KPut Options Held
79.5K-
Black Rock Inc. New York, NY2.58MShares$855 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$838 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT967KShares$321 Million2.15% of portfolio
-
Invesco Ltd. Atlanta, GA807KShares$267 Million0.07% of portfolio
-
State Street Corp Boston, MA703KShares$233 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.3B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...